Management of Norovirus in Immunocompromised Patients

Recognition of Increased Risk

Immunocompromised patients with norovirus face significantly higher mortality risk, particularly those hospitalized, elderly, or post-transplant, with chronic and severe infections commonly reported in organ transplant recipients 1, 2
The severity of immunocompromise directly correlates with unreliability of clinical presentation—patients may lack typical inflammatory signs despite severe infection 3

Obtain stool specimens during the acute phase (≤72 hours from onset) for diagnosis by RT-qPCR, as this is the most reliable diagnostic method for norovirus 4, 5
Perform genotyping on norovirus-positive stool specimens to identify specific viral strains and track potential transmission patterns 4, 5
Test for Clostridioides difficile and its toxin in all cases of diarrhea, as immunocompromised patients are at increased risk for C. difficile-associated diarrhea 6, 7

Initiate aggressive oral rehydration therapy immediately, as this is the cornerstone of treatment for norovirus gastroenteritis 1, 2
The American College of Physicians and the Infectious Diseases Society of America recommend monitoring closely for dehydration, electrolyte imbalances, and nutritional status, as chronic infection can lead to severe malnutrition and cachexia, although the exact guideline is not specified in the provided text 1, 2

Isolate patients until 24-48 hours after complete symptom resolution in institutional settings (hospitals, long-term care facilities) 4, 5
For healthcare workers and food handlers, exclude from work until 48-72 hours after symptom resolution 4, 5
Promote rigorous hand hygiene with soap and running water for a minimum of 20 seconds, as this is the most effective method to reduce norovirus contamination 4, 5, 9

Evaluate for other opportunistic pathogens including Cryptosporidium, Cyclospora, microsporidia, Cystoisospora belli, CMV, and MAC, particularly in HIV-infected patients 1, 2
Specifically request testing for Cryptosporidium and Cyclospora, as standard ova and parasite examinations do not include these organisms 1, 2
Consider noninfectious etiologies including adverse effects of antiretroviral therapy or chemotherapy as causes of persistent diarrhea 1, 2

Avoid antimotility agents in immunocompromised patients with acute diarrhea, as they may mask serious complications and aggravate ileus 10